A review of multiple studies indicates that low-dose GLP-1 RAs can reduce pro-inflammatory markers such as TNF-alpha, IL-6, and hsCRP, contributing to improved quality of life and health outcomes in individuals with inflammatory conditions, including cardiovascular and kidney diseases
Rapid weight loss from GLP-1 medications like Ozempic has occasionally been linked to nerve problems in the feet, including peroneal nerve neuropathy (sometimes called drop foot) or other forms of neuropathy that cause tingling, coldness, or numbness
Max Hemphill Patient All five stars, six if possible
[PubMed] 7
Development and testing of advanced delivery strategies, such as nanoformulations and prodrugs, are needed to overcome bioavailability challenges and improve central nervous system penetration and target engagement
Contents What are GLP-1 medications